Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M235Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M3.4EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)22.3Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.7PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M5,650,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PBE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PBE is held by these investors:



PBE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48338.71view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94145.51view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1724364.71view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.362958.09view
Bebek, IvanDirector 2017-01-16Buy8,990$3.381130.47view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4110043.9view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.9149.01view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.27563.32view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38-31.12view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1527626.67view

Quarterly/Annual Reports about PBE:

    News about PBE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Time to Buy Biotech ETF? Mar 13 2017
    Time to Buy Biotech ETFs? Mar 13 2017
    Trump's Immigration Plans an Overhang on Biotech ETFs? Mar 02 2017
    A Look at Incyte’s Product Portfolio Mar 01 2017
    What Lies Ahead for Biotech ETFs in Trump Era? Jan 27 2017
    Trump Attacks Biotech & Pharma: ETFs Bleed Jan 12 2017
    What’s in Incyte’s Product Portfolio? Jan 09 2017
    POWERSHARES EXCHANGE TRADED FUND TRUST Financials Dec 15 2016
    Neurocrine Biosciences Pursues Women’s Health Segment with Elagolix Dec 02 2016
    Biotech ETFs Slumping on Q3 Results Nov 08 2016
    4 Frightful ETFs of This Year Oct 27 2016
    Is the Dividend ETF Bull Run Over? Oct 07 2016
    3 ETFs to Buy for a Media Merger Frenzy Oct 05 2016
    How Are Eli Lilly’s Business Segments Performing? Sep 01 2016
    Why Did Hormel Foods Increase Its Fiscal 2016 Guidance? Aug 24 2016
    The Zacks Analyst Blog Highlights: PureFunds ISE Junior Silver ETF, SPDR S&P Technology Hardware... Aug 23 2016
    Top Tech ETFs Of 2016 Aug 04 2016
    This Seasonal ETF Is Ripe For The Pickin' This Summer Jul 27 2016
    A Consumer Staples ETF To Feast On Jul 25 2016
    Restaurants Reflect Consumption Trends (Literally) Jul 23 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)